BrainsWay Ltd.

$15.28+2.62%(+$0.39)
TickerSpark Score
86/100
Strong
50
Valuation
90
Profitability
100
Growth
88
Health
100
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BWAY research report →

52-Week Range83% of range
Low $5.00
Current $15.28
High $17.35

Companywww.brainsway.com

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases.

CEO
Hadar Levy
IPO
2019
Employees
120
HQ
Jerusalem, IL

Price Chart

+185.61% · this period
$17.17$11.14$5.10May 20Nov 18May 20

Valuation

Market Cap
$599.33M
P/E
76.07
P/S
10.78
P/B
7.93
EV/EBITDA
86.38
Div Yield
0.00%

Profitability

Gross Margin
75.42%
Op Margin
8.28%
Net Margin
13.50%
ROE
11.10%
ROIC
5.05%

Growth & Income

Revenue
$52.23M · 28.34%
Net Income
$7.63M · 163.39%
EPS
$0.40 · 365.12%
Op Income
$4.32M
FCF YoY
152.18%

Performance & Tape

52W High
$17.35
52W Low
$5.00
50D MA
$14.81
200D MA
$10.48
Beta
0.22
Avg Volume
169.50K

Get TickerSpark's AI analysis on BWAY

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Mar 18, 26Zangen Abrahamother0
Mar 18, 26Zangen Abrahamother25,000
Mar 18, 26Mitrany Rayten Michal Etyother0
Mar 18, 26Mitrany Rayten Michal Etyother25,000
Mar 18, 26Zacut Davidother0
Mar 18, 26Zacut Davidother0
Mar 18, 26Zacut Davidother0
Mar 18, 26Zacut Davidother25,000
Mar 18, 26Marom Idoother0
Mar 18, 26Marom Idoother17,500

Our BWAY Coverage

We haven't published any research on BWAY yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate BWAY Report →

Similar Companies